News coverage about Walgreens Boots Alliance (NASDAQ:WBA) has trended somewhat positive this week, according to Accern Sentiment Analysis. Accern ranks the sentiment of media coverage by monitoring more than twenty million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Walgreens Boots Alliance earned a news impact score of 0.14 on Accern’s scale. Accern also gave press coverage about the pharmacy operator an impact score of 47.2074924396811 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the near term.
These are some of the news stories that may have effected Accern Sentiment’s scoring:
- Amazon About-Face On Drug Sales Not Surprising To Walgreens And CVS (finance.yahoo.com)
- Detailed Research: Economic Perspectives on General Dynamics, Garmin, Walgreens Boots Alliance, The Home Depot, Facebook, and Apple — What Drives Growth in Today’s Competitive Landscape (finance.yahoo.com)
- Zacks: Brokerages Expect Walgreens Boots Alliance Inc (WBA) Will Announce Quarterly Sales of $33.56 Billion (americanbankingnews.com)
- Express Scripts (ESRX) & Walgreens Boots Alliance (WBA) Head-To-Head Contrast (americanbankingnews.com)
- $1.49 Earnings Per Share Expected for Walgreens Boots Alliance Inc (WBA) This Quarter (americanbankingnews.com)
NASDAQ WBA traded down $0.20 during trading on Tuesday, hitting $66.02. 4,248,639 shares of the stock traded hands, compared to its average volume of 5,893,140. The stock has a market capitalization of $63,288.10, a PE ratio of 12.93, a P/E/G ratio of 1.03 and a beta of 1.16. Walgreens Boots Alliance has a 12-month low of $61.74 and a 12-month high of $87.79. The company has a debt-to-equity ratio of 0.44, a current ratio of 0.90 and a quick ratio of 0.45.
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 12th. Stockholders of record on Friday, May 18th will be paid a $0.40 dividend. This represents a $1.60 annualized dividend and a dividend yield of 2.42%. The ex-dividend date is Thursday, May 17th. Walgreens Boots Alliance’s payout ratio is 31.37%.
A number of research firms have weighed in on WBA. Zacks Investment Research raised Walgreens Boots Alliance from a “hold” rating to a “buy” rating and set a $82.00 target price on the stock in a report on Saturday, January 13th. Pivotal Research set a $70.00 target price on Walgreens Boots Alliance and gave the company a “hold” rating in a report on Thursday, March 29th. BidaskClub downgraded Walgreens Boots Alliance from a “sell” rating to a “strong sell” rating in a report on Thursday, March 22nd. Robert W. Baird restated a “buy” rating and issued a $82.00 price target on shares of Walgreens Boots Alliance in a research report on Thursday, January 4th. Finally, Jefferies Group set a $85.00 price target on Walgreens Boots Alliance and gave the stock a “buy” rating in a research report on Tuesday, April 3rd. One equities research analyst has rated the stock with a sell rating, ten have given a hold rating, thirteen have given a buy rating and one has issued a strong buy rating to the company. Walgreens Boots Alliance presently has a consensus rating of “Buy” and a consensus target price of $83.20.
About Walgreens Boots Alliance
Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.